描述
Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions.
More Figures from This Paper
Figure 1
Experimental results examining from metabolic dysregulation to neurodegenerative pathology, with data points illustrating key findings related to type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.
chart
Figure 3
Measured parameters from a study evaluating from metabolic dysregulation to neurodegenerative pathology, contributing to the overall assessment of type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.
chart
Figure 4
Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.
chartFigure 2
ChartSource Paper
From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease.Cite This Figure
 > Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." *Metabolic brain disease*, 2025. PMID: [41003796](https://pubmed.ncbi.nlm.nih.gov/41003796/)
<figure> <img src="https://pdfs.citedhealth.com/figures/41003796/154.png" alt="Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions." /> <figcaption>Figure 2. Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions.<br> Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." <em>Metabolic brain disease</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/41003796/">41003796</a></figcaption> </figure>